Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Terminated 2Recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Head & Neck 6Breast 3Other 2Genitourinary 2Gastrointestinal 2Tumor-Agnostic 1Lymphoid 1Gynecologic 1

Conditions

Breast Neoplasms 2Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

Trastuzumab 696Paclitaxel 679Cyclophosphamide 634Docetaxel 554Capecitabine 468Letrozole 407Carboplatin 393Fulvestrant 379Doxorubicin 330Tamoxifen 288pembrolizumab 272Anastrozole 252Epirubicin 249exemestane 238pertuzumab 229Bevacizumab 214Radiotherapy 213Gemcitabine 211Vinorelbine 188palbociclib 183Lapatinib 175130-nm albumin-bound paclitaxel 168Albumin-Bound Paclitaxel 156Exercise 147Magnetic Resonance Spectroscopy 145eribulin 144Taxes 134Fluorouracil 131Everolimus 118Cisplatin 118

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Transcutaneous Electric Nerve Stimulation × Breast × Clear all
NCT05368428 2026-05-18

Transcutaneous Electrical Nerve Stimulation in Chemotherapy Induced Peripheral Neuropathy in Patients With Stage I-III Early Stage Breast Cancer

Emory University

Phase NA Terminated
17 enrolled
BreastOther

Anatomic Stage I Breast Cancer AJCC v8

NCT05904340 2024-11-06

Transcutaneous Electrical Acupoint Stimulation on Symptoms Associated with Chemotherapy Induced Peripheral Neuropathy

National Taipei University of Nursing and Health Sciences

Phase NA Recruiting
86 enrolled
Breast

Breast Neoplasms

NCT04936451 2023-08-01

MODYMYO

Institut Cancerologie de l'Ouest

Phase NA Terminated
5 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡